NCT05065736 2026-03-19
Using a PET Imaging Agent, 18F-Clofarabine (CFA), to Measure Deoxycytidine Kinase Activity in Metastatic Cancer
Case Comprehensive Cancer Center
Phase EARLY_PHASE1 Recruiting
Clinical Trials
4 trialsNCT03572283 2025-06-05
Bethanechol Prior to Pancreatic Surgery
Columbia University
Phase EARLY_PHASE1 Completed
NCT03153410 2025-01-09
Pilot Study With CY, Pembrolizumab, GVAX, and IMC-CS4 (LY3022855) in Patients With Borderline Resectable Adenocarcinoma of the Pancreas
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase EARLY_PHASE1 Completed
NCT06612580 2024-09-25
68Ga-AAZTA-NI-093 PET/CT: First-in-human Study
First Affiliated Hospital of Fujian Medical University
Phase EARLY_PHASE1 Recruiting